Chad Smith Email & Phone Number

Cumming, GA, US

North Atlanta, Georgia, United States

Knoxville, Tennessee, United States

• Main responsibility is focusing on key accounts and academic institutions in the gynecological and medical oncology space supporting Zejula while cross collaborating with 4 OAM’s (Knoxville, Nashville, Lexington & St..
• Finished 2020 at 110% collectively for Q2-Q4 with a ranking of 4th out of 24 ROMs
• Coordinated and led a virtual matrix meeting pulling together several key stakeholders (MSL, CTL, Marketing, FRM, RSD, and OAM) focusing on Vanderbilt to develop growth strategy
• Leveraged strong relationship with Med Onc (Dr. Ibach) to create a virtual speaker program opportunity with a key no-see Gyn Onc (Dr. Saunders) to increase Zejula awareness
• Utilized another key relationship with an APN in Asheville at HOPE Women’s Cancer Center to create first touch points in a no-see account completing a virtual speaker program

Knoxville, Tennessee Area

• Launches: o Launched oral Rozlytrek for ROS 1+ and NTRK fusion+ patients in 2019o Launched IV Tecentriq for extensive stage SCLC and 1st line NSCLC in 2019o Launched oral Alecensa for ALK+ patients in 2018 for 1st line.
• Attended ASCO representing Genentech LGI Franchise in 2019 focusing on Tecentriq & Alecensa
• Selected for a four-month Home Office rotation within CT&D training department completing multiple tasks including fully developing two workshops for national All Biooncology meetingo Gaining Commitment & Mastering the.
• Competitively sold IV Avastin with consistent success for 13 years in key indications including NSCLC (launched), mCRC (launched 2nd line), GBM, mBC (launched) and mRCCTeamwork and Collaboration:
• Collaborated with cross functional partners to impact key customers at UT Cancer Institute, Tennessee Cancer Specialists, Erlanger Oncology, Tennessee Oncology and Ballad Health
• Influenced key lung prescribers (UT, TCS, Erlanger) from multiple accounts to attend separate targeted lung programs for Rozlytrek and Tecentriq during important launches

• Performance:o Awarded multiple Outstanding Performance and Exceeded Expectations ratingso Sales Excellence Award in 2014 with a PTP of 111.7% with a ranking of #15/101o BioOnc Summit Winner in 2013 for being in top 2%.
• Courage Award (presented by VP Tom Civik) for breaking counterfeit scandal in 2012o Worked with staff at account to determine vials of multiple products were indeed counterfeit by having pharmacists at other key.

• Sales Excellence Award Winner in 2010 with a PTP of 105.1% and ranked #12/101
• Southern FORCE Interim RPM in 2010 for six months focusing on Sales Analytics
• Won 1st Peer Nominated “Essence of the Division” Award in 2010
• “Geek Squad” Member, leading live and interactive Roambi and OTR Regional Workshops
• Attended CORE Training for two weeks as lung lead training on multiple products
• Sales Excellence Award Winner in 2007 with a PTP of 114.4% and finished ranked #7

Launched Depodur

Knoxville, Tennessee Area